HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$1.00
Day range
$1.00 - $1.00
Year range
$0.73 - $3.68
Market cap
11.83M USD
Avg Volume
11.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (SGD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 205.08K | 46.91% |
Operating expense | 1.27M | 46.51% |
Net income | -868.35K | -21.59% |
Net profit margin | -423.42 | 17.23% |
Earnings per share | — | — |
EBITDA | -995.61K | -50.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SGD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.10M | -57.84% |
Total assets | 7.98M | -20.69% |
Total liabilities | 1.13M | 10.48% |
Total equity | 6.85M | — |
Shares outstanding | 11.83M | — |
Price to book | 1.82 | — |
Return on assets | -34.37% | — |
Return on capital | -37.41% | — |
Cash Flow
Net change in cash
| (SGD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -868.35K | -21.59% |
Cash from operations | -1.05M | -35.02% |
Cash from investing | 475.92K | -68.42% |
Cash from financing | 121.76K | 788.88% |
Net change in cash | -379.73K | -151.53% |
Free cash flow | -633.04K | 6.23% |
About
Founded
2018
Website
Employees
42
